Skip to content

CHITOSAN SALICYLATE

CAS 84563-67-7
68

Safety score · 0–100

Fine

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A chitosan derivative paired with salicylic acid, combining the skin-conditioning benefits of chitosan with the exfoliating and anti-inflammatory properties of salicylate.

Chitosan Salicylate is the salt formed between chitosan (a deacetylated chitin derivative) and salicylic acid. Chitosan is a cationic polysaccharide with film-forming and conditioning properties; salicylate adds keratolytic (exfoliating) and anti-inflammatory activity. The salt form moderates the direct acidity of salicylic acid, potentially reducing irritation. BHA (butylated hydroxyanisole) is a related compound with some concern; salicylates carry restrictions under EU Annex III for certain product types and concentrations. Not a banned ingredient. Skin sensitization is possible in aspirin-sensitive individuals.

Skin benefits

  • Exfoliation (keratolytic)
  • Anti-inflammatory
  • Skin conditioning from chitosan

Known concerns

  • BHA-related concerns (salicylate is a BHA derivative)
  • EU Annex III restrictions apply in some product types
  • Aspirin/salicylate allergy risk
  • Skin irritation at high concentrations

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Check your shelf

Find CHITOSAN SALICYLATE in your products.

Scan any cosmetic product with LuxSense to see if it contains CHITOSAN SALICYLATE and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.